STOCK TITAN

Insider plans sale of 8,929 shares in issuer (NASDAQ: STRO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of STRO has filed a notice of proposed sale under Rule 144 for up to 8,929 shares of common stock through Morgan Stanley Smith Barney LLC on or around 01/20/2026, to be sold on the NASDAQ. The filing lists an aggregate market value of $130,961.76 for these shares and notes that 8,513,529 shares of this class were outstanding. The securities to be sold were acquired via a mix of stock option exercise and restricted stock awards from the issuer in 2025–2026, some paid in cash and some noted as not applicable for cash payment. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the STRO Form 144 filing disclose?

The Form 144 discloses that a shareholder of STRO plans to sell up to 8,929 shares of common stock on the NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $130,961.76.

How many STRO shares are outstanding according to this Form 144?

The notice states that there are 8,513,529 shares of the issuer’s common stock outstanding at the time of the filing.

How were the STRO shares in this Form 144 acquired?

The shares to be sold were acquired from the issuer through a stock option exercise on 01/20/2026 and several restricted stock grants dated 11/21/2025 and 07/08/2025, with some paid in cash and others listed as not applicable for cash payment.

What representation does the seller make in the STRO Form 144?

The seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned STRO share sale?

The planned sale of 8,929 shares of STRO common stock is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.

On which exchange are the STRO shares in this Form 144 expected to be sold?

The Form 144 indicates that the common shares are expected to be sold on the NASDAQ exchange.

Sutro Biopharma

NASDAQ:STRO

View STRO Stock Overview

STRO Rankings

STRO Latest News

STRO Latest SEC Filings

STRO Stock Data

400.68M
8.12M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO